scholarly journals Alzheimer’s disease risk prediction using automated machine learning

2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Xiaoyi Raymond Gao ◽  
Yi‐Ju Li ◽  
Eden R. Martin
2019 ◽  
Vol 15 (7) ◽  
pp. P1632
Author(s):  
Renee George ◽  
Chun Chieh Fan ◽  
Robert Haxton ◽  
Chris Airriess ◽  
Nathan White

PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e77949 ◽  
Author(s):  
Ramon Casanova ◽  
Fang-Chi Hsu ◽  
Kaycee M. Sink ◽  
Stephen R. Rapp ◽  
Jeff D. Williamson ◽  
...  

PLoS ONE ◽  
2019 ◽  
Vol 14 (5) ◽  
pp. e0213653 ◽  
Author(s):  
Ahmed M. Alaa ◽  
Thomas Bolton ◽  
Emanuele Di Angelantonio ◽  
James H. F. Rudd ◽  
Mihaela van der Schaar

2020 ◽  
Vol 9 (9) ◽  
pp. 3016
Author(s):  
Makrina Karaglani ◽  
Krystallia Gourlia ◽  
Ioannis Tsamardinos ◽  
Ekaterini Chatzaki

Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia and its timely diagnosis remains a major challenge in biomarker discovery. In the present study, we analyzed publicly available high-throughput low-sample -omics datasets from studies in AD blood, by the AutoML technology Just Add Data Bio (JADBIO), to construct accurate predictive models for use as diagnostic biosignatures. Considering data from AD patients and age–sex matched cognitively healthy individuals, we produced three best performing diagnostic biosignatures specific for the presence of AD: A. A 506-feature transcriptomic dataset from 48 AD and 22 controls led to a miRNA-based biosignature via Support Vector Machines with three miRNA predictors (AUC 0.975 (0.906, 1.000)), B. A 38,327-feature transcriptomic dataset from 134 AD and 100 controls led to six mRNA-based statistically equivalent signatures via Classification Random Forests with 25 mRNA predictors (AUC 0.846 (0.778, 0.905)) and C. A 9483-feature proteomic dataset from 25 AD and 37 controls led to a protein-based biosignature via Ridge Logistic Regression with seven protein predictors (AUC 0.921 (0.849, 0.972)). These performance metrics were also validated through the JADBIO pipeline confirming stability. In conclusion, using the automated machine learning tool JADBIO, we produced accurate predictive biosignatures extrapolating available low sample -omics data. These results offer options for minimally invasive blood-based diagnostic tests for AD, awaiting clinical validation based on respective laboratory assays. They also highlight the value of AutoML in biomarker discovery.


2021 ◽  
Author(s):  
Xiaopu Zhou ◽  
Yu Chen ◽  
Fanny Ip ◽  
Yuanbing Jiang ◽  
Han Cao ◽  
...  

Abstract Recent advances in genetic sequencing have enabled comprehensive genetic analyses of human diseases, resulting in the identification of numerous genetic risk factors for heritable disorders including Alzheimer’s disease (AD). Such analyses enable AD risk prediction well before disease onset, which is critical for early interventions. However, current analytical approaches have limited ability to accurately estimate the risk effects of genetic variants owing to epistatic effects, which have been overlooked in most previous studies, resulting in unsatisfactory disease risk prediction. Herein, we modeled AD polygenic risk using deep learning methods, which outperformed existing models (i.e., weighted polygenic risk score and lasso models) for classifying disease risk. Moreover, by examining the associations between the outcomes from deep learning methods and multi-omics data obtained from our in-house Chinese AD cohorts, we identified the pathways that are potentially regulated by AD polygenic risk, including immune-associated signaling pathways. Thus, our results demonstrate the utility of deep learning methods for modeling the genetic risks of human diseases, which can facilitate both disease risk classification and the study of disease mechanisms.


2021 ◽  
Author(s):  
Ali Haider Bangash ◽  
Tauseef Ullah ◽  
Inayat Ullah Khan ◽  
Haris Khan ◽  
Arshiya Fatima ◽  
...  

The current state-of-the-art for automated machine learning is adopted to predict Alzheimer's disease (AD) by adopting variables such as Mini Mental State Examination score, estimated total intracranial volume and Atlas Scaling Factor. A macro-weighted average Area under the Response-operating Curve of 0.96 is achieved with a close-to-perfect AD detection score after incorporating the ensemble approach. Such predictive models shall serve to optimize risk stratification and management protocols for this enfeebling ailment.


Sign in / Sign up

Export Citation Format

Share Document